According to our (Global Info Research) latest study, the global CRP Analyzer market size was valued at US$ 253 million in 2025 and is forecast to a readjusted size of US$ 408 million by 2032 with a CAGR of 7.0% during review period.
CRP Analyzer is an in vitro diagnostic instrument used for rapid quantitative or semi-quantitative measurement of C-reactive protein in human whole blood, serum, or plasma. Typical product forms include dedicated or semi-dedicated CRP analyzers, fluorescence immunoassay analyzers, specific protein analyzers, microfluidic POCT platforms, and hematology analyzers equipped with CRP modules. These instruments are mainly used in hospital laboratories, emergency departments, pediatric departments, primary care facilities, outpatient clinics, community healthcare centers, and independent clinical laboratories to support infection and inflammation assessment, disease monitoring, and antibiotic stewardship. Upstream inputs mainly include optical detection modules, photoelectric sensors, pumps and fluidic components, temperature-control modules, embedded control boards, displays, precision plastic parts, reagent cartridge or cuvette interfaces, software algorithms, and calibration and quality-control materials. Downstream customers mainly include hospitals at different levels, primary care institutions, clinics, third-party laboratories, public health institutions, and distributor-service networks. On a narrow-scope, ex-factory instrument-hardware basis, excluding CRP reagents, consumables, calibrators, controls, and the full value of general-purpose chemistry or chemiluminescence platforms, global CRP Analyzer capacity in 2025 is estimated at about 170,000 units, with sales volume of about 118,700 units and an average ex-factory selling price of around USD 2,070 per unit. Portable POCT and fluorescence immunoassay platforms are generally priced lower, while CBC+CRP hematology analyzers, specific protein analyzers, and emergency immunoassay platforms are priced higher. The global industry gross margin is estimated at approximately 32%–48%.
Global market demand is mainly concentrated in hospital laboratories, emergency departments, pediatric departments, primary care facilities, and outpatient clinics. The key value of the market lies in shortening the turnaround time of inflammation-related testing and providing rapid support for infection assessment and treatment decisions. The current supply structure has developed into a multi-platform landscape, including standalone rapid testing devices, fluorescence immunoassay platforms, specific protein analyzers, and hematology systems with combined testing capability. European, U.S., and Japanese suppliers retain advantages in quality systems, regulatory access, result consistency, and high-end medical channels, while Chinese and Korean suppliers are strengthening their market presence through cost efficiency, primary care coverage, faster product iteration, and localized service. Future product development will focus more on faster testing, higher integration, automation, and multi-marker testing. Standalone C-reactive protein testing will continue to have stable demand, but clinical users increasingly prefer combined interpretation with complete blood count, serum amyloid A, procalcitonin, and other infection-related indicators to improve the reliability of infection and inflammation assessment. Platforms that support direct whole-blood testing, simplified operation, rapid result output, stable quality control, and automatic data transmission are more likely to be accepted by emergency departments, pediatric clinics, and primary care institutions. Market growth is mainly driven by improved primary care capacity, tiered healthcare delivery, forward movement of emergency diagnostics, rising pediatric respiratory infection management needs, and stronger requirements for antibiotic stewardship. In primary care and outpatient settings, rapid access to inflammation-related results can improve clinical workflow, reduce patient waiting time, and support more efficient preliminary decision-making by physicians. In hospital laboratories and emergency departments, combined hematology and inflammation testing can reduce sample transfer steps, improve workflow continuity, and help relieve testing pressure during peak patient volumes. Key restraints include product homogenization, intensifying price competition, unclear hardware revenue boundaries under instrument placement models, and differences in regulatory access and clinical practice habits across regions. Some low-end instruments can enter the market through aggressive pricing, but they may face pressure in testing stability, calibration systems, quality control, after-sales maintenance, and long-term consumable supply. The market is expected to concentrate gradually around companies with stable quality systems, broader testing menus, stronger channel service capabilities, and multi-region regulatory access, while smaller companies will still have regional opportunities but less room to compete purely on low prices.
This report is a detailed and comprehensive analysis for global CRP Analyzer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global CRP Analyzer market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CRP Analyzer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CRP Analyzer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global CRP Analyzer market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRP Analyzer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRP Analyzer market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Roche, Aidian, Radiometer, HORIBA, Mindray, Dymind, Getein Biotech, Wondfo, Lifotronic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
CRP Analyzer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immunoturbidimetry
Fluorescence Immunoassay
Other
Market segment by Instrument Format
Handheld / Portable
Benchtop
Other
Market segment by Application
Hospitals
Clinics
Other
Major players covered
Abbott
Roche
Aidian
Radiometer
HORIBA
Mindray
Dymind
Getein Biotech
Wondfo
Lifotronic
Boditech Med
SD Biosensor
EUROLyser Diagnostica
Norman Biological
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe CRP Analyzer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CRP Analyzer, with price, sales quantity, revenue, and global market share of CRP Analyzer from 2021 to 2026.
Chapter 3, the CRP Analyzer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CRP Analyzer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and CRP Analyzer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of CRP Analyzer.
Chapter 14 and 15, to describe CRP Analyzer sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on CRP Analyzer. Industry analysis & Market Report on CRP Analyzer is a syndicated market report, published as Global CRP Analyzer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of CRP Analyzer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.